Study of SOM0226 in Familial Amyloid Polyneuropathy

NCT02191826 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Amyloid Polyneuropathy (FAP)

Interventions

DRUG: SOM0226

Sponsor

SOM Innovation Biotech SA

Collaborators

[object Object]